Serial lactate–procalcitonin interaction identifies a high-risk phenotype in 24-h conditional survivors of post-cardiac arrest syndrome: a CART-based analysis - Top-Institutions - MDSpire

Serial lactate–procalcitonin interaction identifies a high-risk phenotype in 24-h conditional survivors of post-cardiac arrest syndrome: a CART-based analysis

  • By

  • Ali Muhittin Tasdogan

  • Stemi Taha Polat

  • Emin Erdem Kaya

  • Ufuk Ozgur Balica

  • Yavuz Saygili

  • July 1, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Harran University
    Harran University

    Sanliurfa, Turkey

    Key Differentiators

    • Critical Care

  • #2

    Hannover Medical School
    Hannover Medical School

    Hannover, Germany

    Key Differentiators

    • Critical Care

  • #3

    First Affiliated Hospital of Xiamen University
    First Affiliated Hospital of Xiamen University

    Xiamen, China

    Key Differentiators

    • Critical Care

  • #4

    Fundación Valle del Lili
    Fundación Valle del Lili

    Cali, Colombia

    Key Differentiators

    • Critical Care

  • #5

    University Heart and Vascular Centre Hamburg
    University Heart and Vascular Centre Hamburg

    Hamburg, Germany

    Key Differentiators

    • Critical Care

Original Source(s)

Serial lactate–procalcitonin interaction identifies a high-risk phenotype in 24-h conditional survivors of post-cardiac arrest syndrome: a CART-based analysis

  • by Ali Muhittin Tasdogan, Stemi Taha Polat, Emin Erdem Kaya, Ufuk Ozgur Balica, Yavuz Saygili

  • July 1, 2026

Related Content

Establishment and internal-external validation of a 28-day mortality prediction model for septic shock patients with left ventricular systolic dysfunction

Hybrid Management of Subclavian-Axillary Artery Aneurysms in Loeys-Dietz Syndrome After Prior Aortic Arch Repair: Technical Note

Beyond cardiac fibroblasts: research advances on understanding and targeting intercellular communication networks in cardiac fibrosis